Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
BET inhibitors in the treatment of hematologic malignancies: current i | OTT
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Clinical small molecule inhibitors of cell membrane receptors in NF-kB... | Download Scientific Diagram
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation | PLOS Biology
The IKK NF-κB system: a treasure trove for drug development | Nature Reviews Drug Discovery
Transcription Factor Inhibition: Lessons Learned and Emerging Targets: Trends in Molecular Medicine
Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome | Immunology
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports
I Kappa B Kinase Inhibitor - an overview | ScienceDirect Topics
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
Targeting IKKα kinase to prevent tumor progression and therapy resistance
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology
NF-kB inhibitors and activators | Abcam
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
A List of Different NF-JB Inhibitors, Mechanism of Action, and... | Download Table
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink